MedPath

Optimization of Time Parameters of Priming iTBS for Poststroke Motor Rehabilitation

Not Applicable
Not yet recruiting
Conditions
Stroke
Stroke Rehabilitation
Interventions
Device: Theta burst stimulation (TBS)
Behavioral: Robot-assisted training
Registration Number
NCT06612437
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

The goal of this clinical trial is to identify the effect of different time intervals between continuous theta burst stimulation (cTBS) and intermittent theta burst stimulation(iTBS), on top of a standard robot-assisted training (RAT) for sensorimotor rehabilitation in patients with chronic stroke. Using electroencephalography (EEG) to explore potential sensorimotor neuroplasticity underying stroke.

Detailed Description

Delivering Intermittent theta burst stimulation (iTBS) primed with continuous theta burst stimulation (cTBS) to the primary motor cortex (M1) may enhance the facilitatory effect of iTBS on the stimulated M1 through metaplasticity. Previous studies have verified the effectiveness of priming iTBS on improving motor rehabilitation in patients with stroke. However, the optimal time interval between cTBS and iTBS remains unknown. The aim of this clinical trial is to identify the effect of different time intervals between cTBS and iTBS, followed with a standard robot-assisted training (RAT) for sensorimotor rehabilitation in patients with chronic stroke. Using electroencephalography (EEG) to explore potential sensorimotor neuroplasticity. A three-arm randomized controlled trial (RCT) will be performed with an estimated total of 30 patients with chronic stroke. All participants will be randomly allocated to receive 10-session intervention of different TBS protocols (i.e., cTBS-3min interval-iTBS, cTBS-10min interval-iTBS and cTBS-20min interval-iTBS), delivered for 2-4 sessions per week, lasting for 3-4 weeks. All participants will receive a 20-minute standard RAT after each stimulation session. Primary outcome will be Fugl-Meyer Assessment-Upper Extremity scores (FMA-UE). Secondary outcomes will be Action Research Arm Test (ARAT), kinematic outcomes generated during RAT as well as EEG.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. diagnosis of hemorrhagic or ischemic stroke using computed tomography (CT) or magnetic resonance imaging (MRI).
  2. the first-ever stroke with unilateral hemiplegia.
  3. 18-75 years old.
  4. chronic stroke ( ≥ 6 months).
  5. residual hemiparetic upper limb functional level 2-6 in the Functional Test for the Hemiplegic Upper Extremity (FTHUE-HK).
  6. can understand and read Chinese.
  7. signed informed consent.
Exclusion Criteria
  1. diagnosis of any clinically significant or unstable medical disorder.
  2. any contraindications to TMS based on the TMS safety guidelines (Rossi, Hallett, Rossini, & Pascual-Leone, 2011).
  3. inability to follow treatment instructions due to severe cognitive (using the Hong Kong version of the Montreal Cognitive Assessment (MoCA-HK) < 22/30) and communication deficiency.
  4. extreme spasticity over the hemiparetic upper limb (Modified Ashworth Score>2) or severe pain that hindered movement.
  5. a history of neurological or psychiatric disease excluding stroke, or current use of psychoactive medication (sedatives, antipsychotics, antidepressants, etc.).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Priming iTBS with 10-Minute IntervalTheta burst stimulation (TBS)experimental interval(10min) between cTBS and iTBS
Priming iTBS with 3-Minute IntervalTheta burst stimulation (TBS)short interval(3min) between cTBS and iTBS
Priming iTBS with 3-Minute IntervalRobot-assisted trainingshort interval(3min) between cTBS and iTBS
Priming iTBS with 10-Minute IntervalRobot-assisted trainingexperimental interval(10min) between cTBS and iTBS
Priming iTBS with 20-Minute IntervalTheta burst stimulation (TBS)long interval(20min) between cTBS and iTBS
Priming iTBS with 20-Minute IntervalRobot-assisted traininglong interval(20min) between cTBS and iTBS
Primary Outcome Measures
NameTimeMethod
Fugl-Meyer assessment of upper extremity (FMA-UE)Baseline, at the end of treatment, one month after treatmnet

Fugl-Meyer Assessment of upper extremity (FMA-UE) scale is an index to assess the sensorimotor impairment in individuals who have had stroke. It contains motor assessment and sensory assessment. The motor parts includes 33 items assessing the movement, coordination and reflex actions of the shoulder, elbow, forearm and wrist, as well as the hand joints of the paretic arm. Each item consists of a three-point scale (0, 1 and 2), with a total maximum score of 66. The sensory component consists of 6 items assessing light touch and position of the shoulder, elbow, wrist, and thumb. Each item consists of a three-point scale (0, 1, and 2) with a total score of 12 points.

Secondary Outcome Measures
NameTimeMethod
Action Research Arm Test (ARAT)Baseline, at the end of treatment, one month after treatmnet

The ARAT is a clinical assessment for upper limb functional activities for patients with stroke, which mainly focuses on the proximal and distal upper limb function. It consists of four subscales: grasp, grip, pinch and gross movement. It has 19 movement tasks, each graded using a four-point scale (total scores range from 0 to 57) (McDonnell, 2008). The MCID of ARAT is 5.70 points (Van der Lee et al., 2001).

Trial Locations

Locations (1)

The Hong Kong Polytechnic University

🇭🇰

Hong Kong, HK, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath